Recommendations for Piperacillin/Tazobactam Susceptibility Testing Against Enterobacterales
Author Information
Author(s): Lodise Thomas P, Bhavnani Sujata M, Ambrose Paul G, Sader Helio S, Andes David, Pogue Jason M
Primary Institution: Albany College of Pharmacy and Health Sciences
Hypothesis
What are the updated interpretive criteria for piperacillin/tazobactam susceptibility testing against Enterobacterales?
Conclusion
The US Committee on Antimicrobial Susceptibility Testing recommends specific breakpoints for piperacillin/tazobactam susceptibility based on the likelihood of clinically significant AmpC production in Enterobacterales.
Supporting Evidence
- USCAST recommends a TZP susceptibility breakpoint of ≤ 16/4 mg/L for third-generation cephalosporin-susceptible Enterobacterales.
- USCAST does not recommend TZP STIC for Enterobacterales with a moderate to high likelihood of clinically significant AmpC production.
- Data indicate that 15%–20% of Escherichia coli and Klebsiella spp. in the United States are third-generation cephalosporin-nonsusceptible.
Takeaway
This study gives guidelines on how to test if a medicine called piperacillin/tazobactam works against certain germs. It says when it should be used and when it shouldn't.
Methodology
The study involved reviewing existing data and recommendations from various health organizations regarding susceptibility testing criteria.
Potential Biases
Potential conflicts of interest were disclosed by the authors, which may influence the recommendations.
Limitations
The recommendations are based on available data, which may not cover all Enterobacterales species or clinical scenarios.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website